@dideldumdei @SolanuDulcamara @MergencyFe "The combination of GLP-1 receptor agonists and DPP-4 inhibitors is not recommended." https://t.co/IkwXDtUS9I
1,208 followers
207 followers
combining GLP-1 RA and DPP-4 i is not recommended since DPP-4 i as well as GLP-1 RA raises “GLP-1” plasma concentrations. DPP-4 i increase the concentration endogenous GLP-1 concentration. ~2-3-fold, GLP-1 RA lead to 8-10-fold conc. https://t.co/VbCnfCBuN7
28,747 followers
And here is the current clinical DPP4 perspective from .Baptist Gallwitz https://t.co/MGtewDgRgR
4,808 followers
New Research: Clinical Use of DPP-4 Inhibitors: DPP-4 inhibitors were introduced for the treatment of type 2 diabetes in 2006. They stimulate insulin secretion and inhibit glucagon secretion by elevating endogenous GLP-1… https://t.co/rofU7tntJQ #Endocrino